newsfilter
← Latest News
Business Wire·

MyMD Announces U.S. Drug Enforcement Administration (DEA) Determines Supera-CBD™ is not a Controlled Substance or Listed Chemical

-- DEA scientific review concludes Supera-CBD will not be classified as a regulated chemical or require scheduling during development -- MyMD Pharmaceuticals, Inc.® (NASDAQ:MYMD) ("MyMD" or "the Company"), a